NASDAQ
MiNK Therapeutics, Inc. (INKT) has a current ratio of 1.06x as of Monday, May 25, 2026. This represents a 15.80% decrease compared to its 12-month average of 1.26x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.